Table 7.
Patient outcome for 17 ceruminous carcinomas (mean years of follow-up)
| All patients | A, NED | D, NED | D, D | |
|---|---|---|---|---|
| All patients with follow-up | 17 (8.9) | 8 (12.0) | 3 (8.8) | 6 (4.9) |
| Follow-up range | 0.4–21.6 | 3.4–21.6 | 2.5–12.9 | 0.3–11.6 |
| Patients with recurrence | 6 (8.0) | 1 (19.2) | n/a | 5 (5.7) |
| Men | 11 (8.2) | 3 (12.5) | 3 (8.8) | 5 (5.2) |
| Women | 6 (10.4) | 5 (11.8) | n/a | 1 (3.1) |
| Tumor histology: | ||||
| Adenocarcinoma, NOS | 12 (9.1) | 7 (12.8) | 2 (6.7) | 3 (2.0) |
| Adenoid cystic carcinoma | 4 (9.9) | 1 (6.9) | 1 (12.9) | 2 (10.0) |
| Mucoepidermoid carcinoma | 1 (3.1) | n/a | n/a | 1 (3.1) |
A, NED Alive, no evidence of disease; D, NED Dead, no evidence of disease; D, D Dead, with disease; n/a Not applicable; NOS Not otherwise specified